A Highly Potent and Cellularly Active β-Peptidic Inhibitor of the p53/hDM2 Interaction

被引：15

作者：

Hintersteiner, Martin ^{[1
,2
]}

Kimmerlin, Thierry ^{[2
]}

Garavel, Geraldine ^{[2
]}

Schindler, Thorsten ^{[2
]}

Bauer, Roman ^{[2
]}

Meisner, Nicole-Claudia ^{[2
]}

Seifert, Jan-Marcus ^{[2
]}

Uhl, Volker ^{[2
]}

Auer, Manfred ^{[1
,2
]}

机构：

[1] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland

[2] Novartis Inst BioMed Res, Innovat Screening Technol Unit, A-1235 Vienna, Austria

来源：

CHEMBIOCHEM | 2009年 / 10卷 / 06期

关键词：

antitumor agents; beta-peptides; hDM2; inhibitors; p53; protein-protein interactions; HELICAL SECONDARY STRUCTURE; PROTEINOGENIC SIDE-CHAINS; DRUG DISCOVERY; GAMMA-PEPTIDES; DOMAIN; P53; ACIDS;

D O I：

10.1002/cbic.200800803

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：994 / 998

页数：5

共 50 条

[41] Stereochemical studies of hexylitaconic acid, an inhibitor of p53-HDM2 interaction [J].

Nakahashi, Atsufumi ;

Miura, Nobuaki ;

Monde, Kenji ;

Tsukamoto, Sachiko .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (11) :3027-3030

[42] Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14ARF and p53 binding [J].

Stürzenhofecker, B ;

Schlott, T ;

Quentin, T ;

Kube, D ;

Jung, W ;

Trümper, L .

LEUKEMIA & LYMPHOMA, 2003, 44 (09) :1587-1596

[43] Thermodynamic and Computational Studies on the Binding of p53-Derived Peptides and Peptidomimetic Inhibitors to HDM2 [J].

Graesslin, Anja ;

Amoreira, Celine ;

Baldridge, Kim K. ;

Robinson, John A. .

CHEMBIOCHEM, 2009, 10 (08) :1360-1368

[44] HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma [J].

Shi, Yun ;

Takenobu, Hisanori ;

Kurata, Kenji ;

Yamaguchi, Yohko ;

Yanagisawa, Ryu ;

Ohira, Miki ;

Koike, Kenichi ;

Nakagawara, Akira ;

Jiang, Ling Ling ;

Kamijo, Takehiko .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (12) :2324-2334

[45] Human herpesvirus-6B protein U19 contains a p53 BOX I homology motif for HDM2 binding and p53 stabilization [J].

Kofod-Olsen, Emil ;

Pettersson, Susanne ;

Wallace, Maura ;

Abduljabar, Ahmed Basim ;

Oster, Bodil ;

Hupp, Ted ;

Hollsberg, Per .

VIROLOGY, 2014, 448 :33-42

[46] Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system [J].

Datta, Shreya ;

Bucks, Megan E. ;

Koley, Dipankar ;

Lim, Pei Xin ;

Savinov, Sergey N. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (16) :6099-6108

[47] Increased p53 Acetylation By SIRT1 Inhibition Is Required for Optimal Activation of p53 Activity and Significantly Enhances the Ability of HDM2 Inhibitors to Target CML LSC [J].

Duchartre, Yann Pierre Kevin ;

Li, Ling ;

McDonald, Tinisha ;

Ho, YinWei ;

Hsieh, Yao-Te ;

Bhatia, Ravi .

BLOOD, 2014, 124 (21)

[48] Hdm2 and nitric oxide radicals contribute to the p53-dependent radioadaptive response [J].

Takahashi, Akihisa ;

Matsumoto, Hideki ;

Ohnishi, Takeo .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02) :550-558

[49] Effect of Introducing Aib in a Designed Helical Inhibitor of Hdm2-p53 Interaction: A Molecular Dynamics Study [J].

Chattopadhyay, Sarbani ;

Ajani, Haresh ;

Basu, Gautam .

BIOPOLYMERS, 2016, 106 (01) :51-61

[50] Molecular characterization of the hdm2-p53 interaction [J].

Bottger, A ;

Bottger, V ;

GarciaEcheverria, C ;

Chene, P ;

Hochkeppel, HK ;

Sampson, W ;

Ang, K ;

Howard, SF ;

Picksley, SM ;

Lane, DP .

JOURNAL OF MOLECULAR BIOLOGY, 1997, 269 (05) :744-756

← 1 2 3 4 5 →